Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Rauand Duhoky has a total of 65 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Laparoscopic Versus Robot-Assisted Low Anterior Resection With Mesorectal Excision For Rectal Cancer (2014–2021): A Propensity-Weighted Multicentre Cohort Study of Long-term Oncological Outcomes (RESOLUTION)

    by Ritch T.J. Geitenbeek, Rauand Duhoky, Thijs A. Burghgraef, Guglielmo Niccolò Piozzi, Christina A. Fleming, Shamsul Masum, Adrian Hopgood, Timothy Rockall, Quentin Denost, Christophe Taoum, et al.

    BACKGROUND: Robot-assisted total mesorectal excision was introduced to overcome several technical constraints associated with conventional laparoscopic total mesorectal excision in rectal cancer surgery. Nevertheless, data on long-term oncological outcomes remain limited. OBJECTIVE: This study compared long-term oncological outcomes between robot-assisted total mesorectal excision and laparoscopic total mesorectal excision for rectal cancer. DESIGN: Retrospective, multicenter, international cohort study employing inverse probability of treatment weighting to minimize confounding. SETTINGS: Expert centers specialized in colorectal cancer for their respective surgical approach across the United Kingdom, the Netherlands, and France. PATIENTS: There were 1077 rectal cancer patients with at least 3 years of follow-up who underwent either laparoscopic or robot-assisted total mesorectal excision from 2014 to 2021. MAIN OUTCOME MEASURES: The primary outcome was 3-year disease-free survival. Secondary outcomes included 3-year local recurrence, 3-year systemic recurrence, and three-year overall survival. RESULTS: A total of 435.8 laparoscopic and 637.4 robot-assisted cases were analyzed after weighting. More robot-assisted cases were graded as complete total mesorectal excision than in the laparoscopic group (76.5% vs. 87.5%, p < 0.001), but without significant differences in circumferential resection margin positivity, conversion rates, or postoperative complications. Robot-assisted surgery led to higher restorative low anterior resection rates (93.2% vs 80.6%, p < 0.001), and less stoma creation (69.1% vs 80.9%, p < 0.001). No significant differences were found in 3-year disease-free survival (75.1% vs 75.2%, HR 1.04, CI: 0.80-1.34), overall survival (81.6% vs 81.7%, HR 1.14, CI: 0.80-1.61), local recurrence (3.7% vs 3.0%, HR 0.89, CI 0.45-1.80), or systemic recurrence (15.1% vs 15.3%, HR 0.97, CI: 0.69-1.34). LIMITATIONS: Because this is an observational propensity-weighted analysis, these results should be interpreted as an absence of observed differences rather than evidence of equivalence, and residual confounding (including temporal and center-level factors) may remain. CONCLUSION: Robot-assisted surgery was associated with improved pathological specimen grade and more restorative procedures, while no statistically significant differences were observed in 3-year oncological outcomes. See Video Abstract . Clinical study registry: https://www.isrctn.com/ISRCTN75281193.


  • Ten years of robot-assisted versus laparoscopic total mesorectal excision for rectal cancer (short-term RESOLUTION)

    by Rauand Duhoky, Ritch T J Geitenbeek, Guglielmo Niccolò Piozzi, Thijs A Burghgraef, Christina A Fleming, Shamsul Masum, Adrian Hopgood, Timothy Rockall, Quentin Denost, Christophe Taoum, et al.

    Background: Total mesorectal excision is the gold standard for rectal cancer surgery, with laparoscopic and robot-assisted approaches commonly employed. While robot-assisted surgery may offer technical advantages, there is limited evidence comparing short-term outcomes of laparoscopic and robot-assisted techniques, particularly in Western European populations. This study aimed to assess the short-term outcomes of laparoscopic vs robot-assisted total mesorectal excision for rectal cancer. Methods: This multicenter, international, retrospective cohort study included 1749 patients who underwent laparoscopic or robot-assisted total mesorectal excision from January 2014 to January 2024. Inverse probability of treatment weighting was applied to minimize confounding. Primary outcomes were length of stay, operative time, and conversion rates. Secondary outcomes included complications and pathological outcomes within 90 days, and readmissions and reinterventions within 30 days. Results: The final cohort included 680.9 laparoscopic and 1057.5 robot-assisted cases after weighting. Robot-assisted surgery showed lower conversion rates (6.1% vs 3.5%, P = .025), higher rates of primary anastomosis (80.1% vs 92.1%, P < .001), and fewer stoma formations (78.4% vs 63.7%, P < .001). Pathological outcomes indicated a higher rate of complete mesorectal excision in the robot-assisted group (77.2% vs 86.0%, P < .001), though these data were not available for all centers. Operative time was longer in the robot-assisted cohort (181.0 vs 220.0 minutes, P < .001), but no significant differences were observed in postoperative complications, length of stay, anastomotic leakage, or 30-day reintervention rates. Conclusion: Robot-assisted surgery low anterior resection demonstrated improved short-term outcomes with lower conversion rates, higher rates of complete mesorectal excision, and higher restorative procedure rates, which may influence longer term oncological and patient quality of life outcomes. Trial registration: https://www.isrctn.com/ISRCTN75281193


  • Open Access

    An International Multicentre Retrospective Cohort Study Evaluating Robot-Assisted Total Mesorectal Excision in Experienced Dutch, French, and United Kingdom Centres—The EUREKA Collaborative

    by Ritch T. J. Geitenbeek, Charlotte M. S. Genders, Christophe Taoum, Rauand Duhoky, Thijs A. Burghgraef, Christina A. Fleming, Eddy Cotte, Anne Dubois, Eric Rullier, Quentin Denost, et al.

    Background: Robot-assisted total mesorectal excision has been proposed as an alternative to laparoscopic TME for rectal cancer. However, its short-term outcomes and long-term oncological efficacy remain debated, especially in Western populations. This study evaluates the short-term clinical and long-term oncological outcomes of robot-assisted total mesorectal excision performed by experienced surgeons in high-volume European centres. Methods: This multicentre, international, retrospective cohort study included 1390 patients from the EUREKA collaborative dataset who underwent robot-assisted total mesorectal excision for rectal cancer between January 2013 and January 2022. All surgeries were performed by expert surgeons beyond the learning curve. Data were analysed for patient demographics, perioperative outcomes, pathological findings, and three-year survival metrics. Kaplan–Meier analysis was used to evaluate overall and disease-free survival. Results: Of 1390 patients, 60.6% underwent restorative low anterior resection. Conversion to open surgery occurred in 3.7%, and postoperative complications were reported in 28.7%. Anastomotic leakage occurred in 14.7% of patients who underwent restorative low anterior resection. The median operative time was 223 min. R0 resection was achieved in 94.7%, and circumferential resection margin positivity was 5.5%. Three-year overall survival was 90.1%, disease-free survival was 88.6%, and local recurrence was 2.9%. Conclusions: Robot-assisted total mesorectal excision performed by experienced surgeons in high-volume European centres is safe, with low conversion rates, acceptable complication rates, and favourable oncological outcomes. These findings underscore the potential of robot-assisted total mesorectal excision as a standard approach for rectal cancer in specialised settings.


  • Open Access

    Analysis of Local Recurrence After Robotic-Assisted Total Mesorectal Excision (ALRITE): An International, Multicentre, Retrospective Cohort

    by Ritch T. J. Geitenbeek, Rauand Duhoky, Thijs A. Burghgraef, Guglielmo Niccolò Piozzi, Shamsul Masum, Adrian A. Hopgood, Quentin Denost, Ellen van Eetvelde, Paolo Bianchi, Philippe Rouanet, et al.

    Background/Objectives: Rectal cancer is a major global health issue with high morbidity and mortality rates. Local recurrence (LR) significantly impacts patient outcomes, decreasing survival rates and often necessitating extensive secondary treatments. While robot-assisted total mesorectal excision (R-TME) is becoming a preferred method for rectal cancer surgery due to its improved precision and visualisation, long-term data on LR and predictors of recurrence remain limited. This study aims to determine the 3-year LR rate following R-TME and to identify predictors of recurrence to enhance patient selection and the personalisation of treatment. Methods: This retrospective international multicentre cohort study included 1039 consecutive rectal cancer patients who underwent R-TME between 2013 and 2020, with a minimum of 3 years of follow-up. Data from tertiary colorectal centres in the United Kingdom, the Netherlands, Spain, France, Italy, and Belgium were analysed. Potential predictors of LR were identified using backward elimination, and four machine learning models were evaluated for predicting LR. Results: The 3-year LR rate was 3.8%. Significant predictors of LR included advanced clinical M-staging, length of the hospital stay, postoperative ileus, postoperative complications, pathological N-staging, the completeness of resection, and the resection margin distance. The eXtreme Gradient Boosting model performed best for LR prediction, with a final accuracy of 77.1% and an AUC of 0.76. Conclusions: R-TME in high-volume centres achieves low 3-year LR rates, suggesting that robot-assisted surgery offers oncological safety and advantages in rectal cancer management. This study underscores the importance of surgical precision, patient selection, and standardised perioperative care, supporting further investment in robotic training to improve long-term patient outcomes.


  • European multicentre analysis of the implementation of robotic complete mesocolic excision for right‐sided colon tumours

    by Ellen Van Eetvelde, Rauand Duhoky, Guglielmo Niccolò Piozzi, Daniel Perez, Daniel Jacobs‐Tulleneers‐Thevissen, Jim Khan, Paolo Pietro Bianchi, Marcos Gomez Ruiz

    Aim: Complete mesocolic excision (CME) is an oncologically driven technique for treating right colon cancer. While laparoscopic CME is technically demanding and has been associated with more complications, the robotic approach might reduce morbidity. The aim of this study was to assess the safety of stepwise implementation of robotic CME.Method: A multicentre retrospective analysis of prospectively collected data on robotic right colectomy was performed at five European tertiary centres. Patients were classified for type of surgery: R‐RHC (standard right colectomy), R‐impCME (learning cases towards robotic CME defined as R‐RHC with one but not all the hallmarks of CME) or R‐CME (robotic CME). Primary outcomes were overall and severe 30‐day complication rates before and after propensity score matching (PSM) analysis.Results: Five hundred and fifty‐one consecutive patients undergoing robotic surgery for (pre)malignant lesions of the right colon between 2010 and 2020 were included: R‐RHC (n = 101), R‐impCME (n = 135) and R‐CME (n = 315). Baseline characteristics differed for American Society of Anesthesiologists score (p = 0.0012) and preoperative diagnosis of adenocarcinoma (p < 0.001). Procedure time increased by surgical complexity (p < 0.001). Vascular event rates did not differ, with no superior mesenteric vein injuries. Conversion, complication and anastomotic leak rates, time to flatus/soft diet and length of stay (LOS) did not differ. While R‐RHC was performed for a lower rate of malignancies (p < 0.001), lymph node yield was significantly higher in R‐CME (p < 0.001). After PSM, analyses on 186 patients documented no differences in overall and severe 30‐day complication rate, conversion rate, LOS or 30‐day mortality.Conclusion: R‐CME can be implemented without increasing the overall or 30‐day severe complication rate.


  • Open Access

    Mitrofanoff Appendicovesicostomy in Robotic Paediatric Surgery—A Systematic Review

    by Diana Ronconi Di Giuseppe, Harry Claxton, Rauand Duhoky, Guglielmo Niccolò Piozzi, Jim S. Khan

    Introduction: Proper bladder drainage is crucial. Children with bladder dysfunction may require alternative methods like clean intermittent catheterisation (CIC). However, CIC can be challenging for individuals with impairments. The Mitrofanoff procedure provides a solution by connecting the appendix to the bladder and creating a stoma on the skin, allowing for continent catheterisation. Minimally invasive techniques, including robotics, have been adopted recently. The aim of this study is to review the existing literature on robotic Mitrofanoff procedures. Materials and Methods: A systematic review on paediatric robotic Mitrofanoff procedures on the PubMed, Cochrane, and Scopus databases was conducted according to the PRISMA Statement. Critical appraisals of the included studies were performed with the Newcastle Ottawa Scale. Results: Six studies were included about the robotic Mitrofanoff procedure. Sex was reported in 50% of the studies. Ages were within the twelve-year age limit, as per the inclusion criteria. The mean operative time was 499.3 (±171.1) min. Four of the six studies reported a length of stay with a median of 6 days (±4; range 1.8–23). The incidence of complications was in line with established benchmarks. Only one study compared the Mitrofanoff procedure to open surgery, finding similar outcomes but longer operating times. Port placement and surgical strategy was described. Conclusions: Robotics can offer potential advantages for the Mitrofanoff procedure, despite its application still being in its early stages. This study emphasises the potential safety and efficacy of the robotic approach and promotes the need for further prospective high-quality studies.


  • Artificial intelligence real‐time mapping with Eureka during robotic total mesorectal excision for rectal cancer: A video vignette

    by Guglielmo Niccolò Piozzi, Rauand Duhoky, Ania Przedlacka, Diana Ronconi Di Giuseppe, Jim S. Khan


  • Open Access

    Robotic colorectal surgery training: Portsmouth perspective

    by Guglielmo Niccolò Piozzi, Sentilnathan Subramaniam, Diana Ronconi Di Giuseppe, Rauand Duhoky, Jim S. Khan

    This study aims to discuss the principles and pillars of robotic colorectal surgery training and share the training pathway at Portsmouth Hospitals University NHS Trust. A narrative review is presented to discuss all the relevant and critical steps in robotic surgical training. Robotic training requires a stepwise approach, including theoretical knowledge, case observation, simulation, dry lab, wet lab, tutored programs, proctoring (in person or telementoring), procedure-specific training, and follow-up. Portsmouth Colorectal has an established robotic training model with a safe stepwise approach that has been demonstrated through perioperative and oncological results. Robotic surgery training should enable a trainee to use the robotic platform safely and effectively, minimize errors, and enhance performance with improved outcomes. Portsmouth Colorectal has provided such a stepwise training program since 2015 and continues to promote and augment safe robotic training in its field. Safe and efficient training programs are essential to upholding the optimal standard of care.


  • Open Access

    An Institutional Shift from Routine to Selective Diversion of Low Anastomosis in Robotic TME Surgery for Rectal Cancer Patients Using the KHANS Technique: A Single-Centre Cohort Study

    by Rauand Duhoky, Guglielmo Niccolò Piozzi, Marieke L. W. Rutgers, Ioannis Mykoniatis, Najaf Siddiqi, Syed Naqvi, Jim S. Khan

    (1) Background: In recent years, there has been a change in practice for diverting stomas in rectal cancer surgery, shifting from routine diverting stomas to a more selective approach. Studies suggest that the benefits of temporary ileostomies do not live up to their risks, such as high-output stomas, stoma dysfunction, and reoperation. (2) Methods: All rectal cancer patients treated with a robotic resection in a single tertiary colorectal centre in the UK from 2013 to 2021 were analysed. In 2015, our unit made a shift to a more selective approach to temporary diverting ileostomies. The cohort was divided into a routine diversion group treated before 2015 and a selective diversion group treated after 2015. Both groups were analysed and compared for short-term outcomes and morbidities. (3) Results: In group A, 63/70 patients (90%) had a diverting stoma compared to 98/135 patients (72.6%) in group B (p = 0.004). There were no significant differences between the groups in anastomotic leakages (11.8% vs. 17.8%, p = 0.312) or other complications (p = 0.117). There were also no significant differences in readmission (3.8% vs. 2.6%, p = 0.312) or reoperation (3.8% vs. 2.6%, p = 1.000) after stoma closure. After 1 year, 71.6% and 71.9% (p = 1.000) of patients were stoma-free. One major reason for the delay in stoma reversal was the COVID-19 pandemic, which only occurred in group B (0% vs. 22%, p = 0.054). (4) Conclusions: A more selective approach to diverting stomas for robotic rectal cancer patients does not lead to more complications or leaks and can be considered in the treatment of rectal cancer tumours.